Literature DB >> 6795276

Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans.

C A Dinarello, L J Rosenwasser, S M Wolff.   

Abstract

Sub-pyrogenic levels of human leukocytic pyrogen (LP) have been shown to enhance phytohemagglutinin-induced murine thymocyte proliferation. It was concluded that LP is similar to lymphocyte-activating factor (LAF). Since endotoxin stimulates the production of LP and LAF, we attempted to employ in vitro thymocyte proliferation to detect circulating LP/LAF in 12 normal human subjects during experimental endotoxin fever. Sera obtained before and during fever were first mixed with an immunoadsorbent that binds human LP/LAF, and then the dissociated material was added to thymocyte cultures. Material derived from sera obtained during the maximum fever (3 to 4 hr after endotoxin) was markedly suppressive for thymocyte proliferation in vitro. The appearance of this suppressive effect correlated with the profound lymphopenia observed in the subjects. This suppressor factor(s) was nondialyzable and was destroyed at 70 degrees C, and its suppressive effects inhibited the lymphocyte-activating property of LP/LAF. In addition, the suppression of PHA responses did not appear to be modulated by prostaglandin synthesis. The results demonstrate that a factor circulates during endotoxin fever in humans that suppresses in vitro thymocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795276

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease.

Authors:  J Brynskov; M B Hansen; C Reimert; K Bendtzen
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors.

Authors:  J B Smith; M H Bocchieri; L Sherbin-Allen; M Borofsky; J L Abruzzo
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

4.  Evidence of a plasma-mediated "window" of immunodeficiency in rats following trauma.

Authors:  C D Mills; M D Caldwell; D S Gann
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

5.  How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?

Authors:  Angelo Spinello; Elena Vecile; Antonio Abbate; Aldo Dobrina; Alessandra Magistrato
Journal:  J Chem Inf Model       Date:  2019-01-10       Impact factor: 4.956

6.  Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Authors:  J W Mier; G Vachino; J W van der Meer; R P Numerof; S Adams; J G Cannon; H A Bernheim; M B Atkins; D R Parkinson; C A Dinarello
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

7.  Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.

Authors:  S J Hopkins; M Humphreys; M I Jayson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

9.  Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1.

Authors:  K M Brown; A V Muchmore; D L Rosenstreich
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production.

Authors:  L Borish; M S King; J J Mascali; S Johnson; B Coll; L J Rosenwasser
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.